Volume 22, Number 5—May 2016
Research
Acute Human Inkoo and Chatanga Virus Infections, Finland
Table 4
Virus and patient no. |
Illness progression |
Additional findings |
INKV | ||
1 | Day 1: fever 38°C, influenza-like symptoms | Elevated HHV-6 antibody levels from same sample |
Day 3: disoriented | ||
Day 6: hospitalized, abnormal EEG, CAL IgM+ | ||
Day 7: psychotic but discharged | ||
Day 10: follow-up EEG shows same abnormalities | ||
3 mo later: EEG almost normal | ||
2 | Day 1: fever 39.5°C, headache, nuchal rigidity, sore throat before fever, hospitalized | Tick bite 1 mo earlier, erythema migrans; day 1: BorrAb neg |
Day 2: nuchal rigidity, headache deteriorating, slowness but oriented | ||
Day 3: discharged, CAL IgM+ | ||
Day 5: headache again, hospitalized | ||
Day 6: discharged | ||
3 | Day 1: vomiting | |
Day 2: stomach pain, diarrhea, seizures, hospitalized | ||
Day 3: fever 38.3°C, drowsiness, convulsions | ||
Day 4: More seizures, small changes in EEG | ||
Day 5: CAL IgM+ | ||
Day 8: discharged | ||
4 | Day 1: fever 37.9°C, sore throat | Tick bite 3 wks earlier |
Day 3: CAL IgM+ | ||
Day 4: nausea and vomiting | ||
Day 5: fever 39°C, headache, nuchal rigidity, hospitalized | ||
Day 10: recovered and discharged |
||
CHATV | ||
1 | Day 1: vomiting continuing for 3 d | |
Day 4: fever, hospitalized, disoriented at night | ||
Day 7: frontal headache, normal head CT and abdominal ultrasound | ||
Day 12: discharged, CAL IgM+ | ||
2 | Day 1: fever 39°C, back pain | Back injury 2 wks earlier |
Day 7: hospitalized, high fever, back pain almost resolved | ||
Day 7–22: temporal pain, trembling of hands, fluctuating fever | ||
Day 17: CAL IgM+ | ||
Day 23: discharged |
*BorrAb, Borrelia antibody test; CHATV, Chatanga virus; CT, computer tomographic scan; EEG, electroencephalogram; HHV, human herpesvirus; INKV, Inkoo virus. CAL IgM+ indicates the day when IgM for California encephalitis group viruses was observed.
Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.